Last reviewed · How we verify
NCT06123949
The Effect of Galvanic Stimulation on vHIT and VEMP Tests
NA trial testing Galvanic Vestibular Stimulation in Vestibular System Disorder in 30 participants. Completed in 10 September 2020.
10 June 2020
Quick facts
| Lead sponsor | Istanbul Medipol University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 25 August 2019 |
| Primary completion | 10 June 2020 |
| Estimated completion | 10 September 2020 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Galvanic Vestibular Stimulation
Conditions studied
- Vestibular System Disorder — all drugs for Vestibular System Disorder →
Sponsor
Istanbul Medipol University Hospital
Who can join
Adults 18 to 22, any sex, with Vestibular System Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: Galvanic vestibular stimulation (GVS) is a well-established technique with a history spanning over a century, primarily used to manipulate the vestibular system. Recent interest has surged in its potential for understanding human vestibular function and aiding in functional recovery. GVS applies electrical currents to the mastoid region, modulating vestibular afferents, and induces specific effects based on the participant's posture and current polarity. While GVS's impact on the central nervous system and its potential to aid in functional recovery have been studied, its immediate effects on vestibular reflexes remain less explored. Methods: In this study, thirty healthy adult participants underwent ocular and cervical vestibular evoked myogenic potential (VEMP) tests, as well as the velocity Head Impulse Test (vHIT) before and immediately after one hour of GVS application. Statistical analyses were performed to assess changes in VEMP and vHIT results.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06123949
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Galvanic Vestibular Stimulation
Trials testing the same drug.
- NCT04859868 — Non-pharmaceutical Motion Sickness Mitigation · NA · completed
- NCT03831594 — Combining Physical Therapy With Vestibular Stimulation to Improve Postural Stability in Pusher's Syndrome · NA · withdrawn
- NCT02979314 — The Influence of GVS on Mental Transformation · NA · completed
Other Istanbul Medipol University Hospital trials
Trials by the same sponsor.
- NCT07508371 — Menthol Massage for Post-Bypass Pain & Anxiety · NA · not yet recruiting
- NCT07575477 — Comparison Of Early Mobilization And Electrical Stimulation On Functional Recovery After Lumbar Disc Herniation Surgery · NA · not yet recruiting
- NCT07525115 — Effects of Proprioceptive Neuromuscular Facilitation-Based Lower Extremity Training on Balance, Gait, and Functional Ind · NA · not yet recruiting
- NCT07467278 — Low-FODMAP Diet and Intestinal Permeability in Patients With Irritable Bowel Syndrome · NA · not yet recruiting
- NCT07468864 — Validity of the Turkish Situational Vertigo Questionnaire · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06123949 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Medipol University Hospital
- Last refreshed: 13 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06123949.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing